Fda Launches Real-Time Access Plan For Clinical Trial Data With AstraZeneca And Amgen — The FDA announced a new initiative that would let its reviewers access clinical trial information in real time, aiming to speed and strengthen oversight. AstraZeneca and Amgen are already…

— BizToc (@biztoc.com) 2026-04-28T23:01:03.419Z

"This is setting off alarm bells because it suggests the president is doing an end-run around the FDA’s normal scientific processes, quite possibly because he wants to quiet a politically influential podcaster who has been giving him grief over Iran."

— The Bulwark (@thebulwark.com) 2026-04-28T23:00:59.278Z